Tricyclic compounds for the treatment of cancer

TW202629203APending Publication Date: 2026-07-16F HOFFMANN LA ROCHE & CO AG

0 Cites 0 Cited by

Patent Information

Application Number: TW114142076
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-10-30
Publication Date: 2026-07-16

Application Information

Patent Timeline

30 Oct 2025

Application

TW114142076

16 Jul 2026

Publication

TW202629203A

IPC: A61K31/535; A61K31/403; A61K31/427; A61K31/44; A61K31/497; A61K31/501; A61P35/00

Inventors: 陳建國; 郭磊

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to compounds of formula (I), , wherein R1 to R6, M, L, T and W are as described herein, and their pharmaceutically acceptable salt, enantiomers and diastereomers thereof, and compositions including the compounds and methods of using the compounds.

Need to check novelty before this filing date? Find Prior Art